Flavaspidic acid BB combined with mupirocin improves its anti-bacterial and anti-biofilm activities against Staphylococcus epidermidis.

Cai, Zhiling; Mo, Zitong; Zheng, Shiqian; Lan, Shihua; Xie, Shengjun; Lu, Jinghui; Tang, Chunping; Shen, Zhibin

Cai, Zhiling; Mo, Zitong; Zheng, Shiqian; Lan, Shihua; Xie, Shengjun; Lu, Jinghui; Tang, Chunping; Shen, Zhibin.

Afiliação

Cai Z; School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, China.
Mo Z; School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, China.
Zheng S; School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, China.
Lan S; School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, China.
Xie S; School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, China.
Lu J; The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.
Tang C; School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, China.
Shen Z; School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, China. szb8113@126.com.

BMC Microbiol ; 22(1): 179, 2022 07 15.

Article em En | MEDLINE | ID: mdl-35840879

Assuntos

Staphylococcus aureus Resistente à Meticilina; Staphylococcus epidermidis; Antibacterianos/farmacologia; Biofilmes; Butirofenonas; Testes de Sensibilidade Microbiana; Mupirocina/farmacologia

Palavras-chave

Biofilm; Combination therapy; Flavaspidic acid BB; Staphylococcus epidermidis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Staphylococcus epidermidis / Staphylococcus aureus Resistente à Meticilina Idioma: En Revista: BMC Microbiol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google